As per MRFR analysis, the UK Continuous Glucose Monitoring System Market Size was estimated at 190.8 (USD Million) in 2023.The UK Continuous Glucose Monitoring System Market is expected to grow from 208.35(USD Million) in 2024 to 600 (USD Million) by 2035. The UK Continuous Glucose Monitoring System Market CAGR (growth rate) is expected to be around 10.093% during the forecast period (2025 - 2035).
Key UK Continuous Glucose Monitoring System Market Trends Highlighted
The market for continuous glucose monitoring systems in the UK is expanding significantly due to rising diabetes prevalence and awareness of diabetes care. The need for sophisticated monitoring technologies is rising as the National Health Service (NHS) keeps highlighting the value of individualized healthcare solutions.
The advantages of continuous glucose monitoring, such as better glycaemic management and a lower risk of complications, are becoming more widely acknowledged by patients and healthcare professionals. The NHS has recently taken steps to improve access to diabetes technologies, demonstrating strong policy support that promotes patient uptake.
Despite these advancements, there is still potential to grow the user base, especially among Type 2 diabetics who might not be using continuous glucose monitoring devices at the moment.
As medical practitioners continue to look for more efficient solutions for better diabetes control, technological advancements like smaller, more precise sensors and improved data analytics offer opportunities for expansion.
Furthermore, the opportunity to deliver a thorough picture of patient health through integration with digital health platforms is a chance to expedite care. Recent developments in the UK indicate that telemedicine and remote patient monitoring are becoming more and more popular, especially as a result of difficulties like the COVID-19 epidemic.
User-friendly gadgets that facilitate simple data sharing with medical practitioners are becoming more and more important as the trend towards digital health solutions continues.
This convenience encourages a proactive approach to diabetes care in the UK by increasing patient involvement in their own health management. All things considered, the market is changing to satisfy the demands of a changing healthcare environment.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
UK Continuous Glucose Monitoring System Market Drivers
Rising prevalence of diabetes in the UK
The increasing number of diabetes cases in the UK is a primary driver for the UK Continuous Glucose Monitoring System Market. According to the National Health Service (NHS), diabetes prevalence has more than doubled in the past 20 years, with approximately 4.9 million people diagnosed with diabetes in the UK as of 2022.
This substantial rise in patient numbers necessitates more effective monitoring solutions, such as continuous glucose monitoring systems. Organizations such as Diabetes UK are advocating for better management tools, leading to growing demand for these technologies.
With an estimated cost of diabetes management reaching 10% of the NHS budget, the push for innovations in glucose monitoring systems is crucial to improve patient outcomes and reduce economic strain.
As patients, healthcare professionals, and organizations increasingly recognize the benefits of Continuous Glucose Monitoring Systems in managing diabetes, the UK Continuous Glucose Monitoring System Market is anticipated to expand significantly.
Technological advancements in glucose monitoring
The rapid advancement in technology, including the development of more accurate and user-friendly continuous glucose monitoring devices, is propelling growth in the UK Continuous Glucose Monitoring System Market. Innovations such as real-time data analysis, mobile app integration, and enhanced sensor accuracy are just a few features driving adoption.
According to the UK government's Innovation Strategy, the medical technology sector is projected to experience factors such as artificial intelligence and digital health integration, fostering further advancements in glucose monitoring technologies.
Major companies in the industry, like Dexcom and Abbott, are at the forefront of these innovations, ensuring improved patient experience, which subsequently drives the market growth.
Increased government initiatives and funding
Government support and initiatives aimed at increasing access to diabetes care and management tools significantly contribute to the growth of the UK Continuous Glucose Monitoring System Market. The NHS has introduced new funding for continuous glucose monitoring systems as part of its Diabetes Prevention Program, which aims to improve health outcomes for diabetic patients.
The NHS Long Term Plan has also pledged to expand the provision of continuous glucose monitors for Type 1 diabetes patients. This funding directly incentivizes healthcare providers to adopt these innovative systems, resulting in higher market demand and facilitating the growth of the UK Continuous Glucose Monitoring System Market in the coming years.
UK Continuous Glucose Monitoring System Market Segment Insights
Continuous Glucose Monitoring System Market Application Insights
The UK Continuous Glucose Monitoring System Market, particularly within the Application segment, showcases robust growth and opportunities encompassing critical areas such as Diabetes Management, Critical Care, and Sports Nutrition.
Diabetes Management stands out as a dominant application, reflecting the increasing prevalence of diabetes in the UK, which has prompted a shift towards personalized care solutions.
The integration of Continuous Glucose Monitoring Systems into day-to-day diabetes management allows for real-time tracking and better glycemic control, proving to be essential in enhancing patient outcomes while reducing healthcare costs.
The Critical Care application segment is gaining traction, driven by the heightened need for accurate and continuous glucose monitoring in hospital settings, especially for patients undergoing intensive treatments.
This demand is further fueled by advancements in technology that enable hospitals to integrate continuous monitoring into their patient management systems seamlessly. Sports Nutrition also emerges as a noteworthy application, as athletes and fitness enthusiasts increasingly leverage continuous monitoring to optimize their performance through precise glucose management.
The demand in this segment highlights the shift towards a more health-conscious society, where maintaining optimal fuel levels for sports and exercise is pivotal.
Taken together, these applications illustrate the diverse potential of Continuous Glucose Monitoring Systems in improving health management across different sectors while contributing significantly to the overall growth of the UK Continuous Glucose Monitoring System Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Continuous Glucose Monitoring System Market Product Type Insights
The UK Continuous Glucose Monitoring System Market encompasses a variety of product types that play crucial roles in diabetes management and patient care. The segment includes Sensors, Transmitters, Receivers, and Integrated Devices, each contributing uniquely to the market's functionality and efficacy. Sensors are pivotal as they provide real-time glucose data, driving patient adherence and improving overall health outcomes.
Transmitters support these sensors by wirelessly communicating glucose levels to devices, enhancing user experience and accessibility. Receivers are essential for displaying this data and helping healthcare providers and patients make informed decisions. Integrated Devices combine multiple functionalities into a single unit, providing convenience and streamlining data management for users.
This segmentation reflects the diverse needs within the UK, where there is a growing demand for reliable and innovative solutions in diabetes healthcare. With an increasing prevalence of diabetes, advancements in these product types are crucial for enhancing self-management and improving the quality of life for patients.
The overall UK Continuous Glucose Monitoring System Market benefits from these innovations, driving market growth and fostering a positive environment for further developments in technology and patient care.
Continuous Glucose Monitoring System Market End-user Insights
The UK Continuous Glucose Monitoring System Market is significantly influenced by its End-user categorization, which includes Hospitals, Homecare, and Diabetes Clinics. Hospitals play a crucial role as they require advanced monitoring systems to manage acute diabetic patients and ensure effective treatment.
The growing prevalence of diabetes in the UK emphasizes the need for improved patient care in these settings. Home care is becoming increasingly important as patients prefer managing their diabetes at home, leading to a rising demand for user-friendly monitoring devices that can improve lifestyle and health outcomes.
Additionally, Diabetes Clinics serve as specialized hubs focused on providing personalized care, education, and disease management resources, thereby bolstering the overall effectiveness of glucose monitoring strategies.
The combination of these sectors illustrates a comprehensive approach to managing diabetes in the UK, reflecting a significant shift towards patient-centric care and the use of technology.
The expansion of these End-user segments aligns with the upward trends in health awareness and advances in monitoring technology, presenting important growth opportunities within the UK Continuous Glucose Monitoring System Market.
Continuous Glucose Monitoring System Market Technology Insights
The Technology segment of the UK Continuous Glucose Monitoring System Market plays a pivotal role in advancing diabetes management solutions. Among the various technological approaches, Microdialysis stands out for its ability to provide real-time glucose measurements in interstitial fluid, which is crucial for timely intervention in diabetes care.
Spectroscopy technology offers non-invasive methods to gauge glucose levels, appealing to a growing demand for user-friendly health monitoring. Meanwhile, Electrochemical methods, widely adopted for their reliability and precision, dominate the market due to their effectiveness in detecting glucose fluctuations.
As the UK government emphasizes the importance of diabetes management through initiatives and healthcare advancements, the integration of these technologies is critical for improving patient outcomes and delivering innovative solutions. Each technology contributes uniquely to the UK Continuous Glucose Monitoring System Market, promising enhanced accuracy, user engagement, and overall industry growth.
UK Continuous Glucose Monitoring System Market Key Players and Competitive Insights
The UK Continuous Glucose Monitoring System Market is undergoing significant evolution, driven by increasing diabetes prevalence and a growing emphasis on personalized healthcare. As patients and healthcare providers alike seek effective management solutions for diabetes, the competitive landscape is expanding, with various players offering innovative technologies and products.
The demand for continuous glucose monitoring (CGM) devices is rising as they provide real-time data, facilitating better decision-making and improving patient outcomes. In this environment, companies are focusing on research and development to enhance the functionality and accuracy of their systems.
The market dynamics are being further influenced by regulatory changes, technological advancements, and an increasing number of partnerships and collaborations aimed at creating comprehensive diabetes management solutions.
Acon Laboratories has carved out a notable presence in the UK Continuous Glucose Monitoring System Market through its commitment to delivering reliable and accurate diabetes management solutions. The company is recognized for its emphasis on quality and efficiency in its product offerings.
Acon Laboratories focuses on developing user-friendly devices that cater to both healthcare professionals and patients, ensuring ease of use and accessibility. Its strengths lie in its ability to leverage advanced technology to produce devices that not only meet regulatory standards but also fulfill the specific needs of UK patients.
By fostering strong relationships with healthcare providers and investing in market research, Acon Laboratories continues to enhance its competitive stance in the UK market. Nova Biomedical has established a reputation in the UK Continuous Glucose Monitoring System Market, driven by its innovative product line that offers a range of advanced glucose monitoring solutions.
The company provides key products that aim to enhance blood glucose management, focusing on accuracy and real-time monitoring capabilities that are crucial for effective diabetes management. Nova Biomedical's strengths are evident in its commitment to research and development, which has led to the introduction of cutting-edge technology that aligns with patient needs.
The company has also engaged in strategic partnerships and potential mergers, positioning itself to expand its market presence further. Through its robust product offerings and strategic initiatives, Nova Biomedical maintains a competitive edge within the UK market, catering to a growing demand for comprehensive diabetes management tools.
Key Companies in the UK Continuous Glucose Monitoring System Market Include:
UK Continuous Glucose Monitoring System Market Developments
The UK Continuous Glucose Monitoring System Market has seen substantial developments recently, particularly with advancements in product innovation and increased collaboration among key players. Companies such as Abbott, Dexcom, and Medtronic have been actively expanding their product lines, improving user interfaces and integration with mobile applications to enhance patient experience.
In November 2022, Dexcom launched its latest CGM technology, which has been well-received among users for its accuracy and reliability. The UK government continues to support diabetes management initiatives, indicating a rising demand for continuous monitoring solutions, with over 4.9 million people diagnosed with diabetes as of early 2023.
In terms of mergers and acquisitions, Medtronic announced in January 2023 its acquisition of a smaller data analytics company to bolster its Digital Health initiatives. The overall market valuation has increased, driven by rising diabetes prevalence and growing awareness of glucose monitoring's importance.
Trends since 2021 have emphasized early intervention and personalized healthcare, placing CGM devices at the forefront of diabetes management. Moreover, sectors like Insulet and Nova Biomedical are focusing on expanding their presence through strategic partnerships and enhancing product accessibility across the UK.
UK Continuous Glucose Monitoring System Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 190.8(USD Million) |
| MARKET SIZE 2024 | 208.35(USD Million) |
| MARKET SIZE 2035 | 600.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.093% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Acon Laboratories, Nova Biomedical, B. Braun, Medtronic, Dexcom, Senseonics, Ascensia Diabetes Care, Insulet, Zhongshan Jialong, GlucoMe, Roche, DreaMed Diabetes, Abbott, LifeScan |
| SEGMENTS COVERED | Application, Product Type, End User, Technology |
| KEY MARKET OPPORTUNITIES | Rising diabetes prevalence, Technological advancements in devices, Increasing awareness and education, Integration with digital health platforms, Expansion in telehealth services |
| KEY MARKET DYNAMICS | rising diabetes prevalence, technological advancements, increasing awareness, growing healthcare expenditure, favorable reimbursement policies |
| COUNTRIES COVERED | UK |
Frequently Asked Questions (FAQ) :
The expected market size of the UK Continuous Glucose Monitoring System Market in 2024 is 208.35 million USD.
By 2035, the projected market size for the UK Continuous Glucose Monitoring System Market is 600.0 million USD.
The expected CAGR for the UK Continuous Glucose Monitoring System Market from 2025 to 2035 is 10.093%.
In 2024, the Diabetes Management application segment is expected to have a market share valued at 100.0 million USD.
The Critical Care application segment is projected to grow to 210.0 million USD by 2035.
By 2035, the expected market size of the Sports Nutrition application segment is 90.0 million USD.
Major competitors in the UK Continuous Glucose Monitoring System Market include companies such as Dexcom, Medtronic, and Abbott.
Growth opportunities in the UK Continuous Glucose Monitoring System Market from 2025 to 2035 include advancements in technology and increasing adoption for diabetes management.
Challenges faced by the UK Continuous Glucose Monitoring System Market include regulatory hurdles and competition from alternative diabetes management solutions.
The current global scenario impacts the UK Continuous Glucose Monitoring System Market by influencing investment decisions and innovation in healthcare technology.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
